Stocks
RNA Atrium Therapeutics, Inc.

RNA

Atrium Therapeutics, Inc.

Company with tickers: RNA

CIK

2093101

CUSIP

04965N104

Shares Outstanding

15,514,966

Price Holdings Short Volume Short Interest Fails to Deliver SEC Filings Earnings Calls Insider Trading Congress Trades

Date	Insider	Role	Type	Shares	Price	Value	After
2026-02-27	Boyce Sarah	Director	Award	20,000	—	—	20,000
2026-02-27	BOESS CARSTEN	Director	Award	20,000	—	—	20,000
2026-02-27	WILSON TROY EDWARD	Director	Award	20,000	—	—	20,000
2026-02-27	Flanagan W. Michael	Director	Award	20,000	—	—	20,000
2026-02-27	Skerjanec Simona	Director	Award	20,000	—	—	20,000
2026-02-26	Kenney Stephanie	See Remarks	Other	5,460	—	—	5,460
2026-02-26	Flanagan W. Michael	Director	Other	54,786	—	—	54,786
2026-02-26	BOESS CARSTEN	Director	Other	11,005	—	—	11,005
2026-02-26	Boyce Sarah	Director	Other	265,086	—	—	265,086
2026-02-26	Younis Husam	Chief Scientific Officer	Other	22,657	—	—	22,657
2026-02-26	Skerjanec Simona	Director	Other	5,902	—	—	5,902
2026-02-26	WILSON TROY EDWARD	Director	Other	10,360	—	—	10,360
2026-02-26	Gallagher Kathleen P.	Director, See Remarks	Other	28,861	—	—	28,861
2026-02-26	Winslow Brendan R.	Chief Financial Officer	Other	13,601	—	—	13,601
2026-02-26	Hoyos Rocio Martin	Chief Strategy Officer	Other	16,660	—	—	16,660
2026-02-26	Hughes Steven George	Chief Development Officer	Other	43,097	—	—	43,097